These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15834042)

  • 1. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves.
    Achiron A; Polliack M; Rao SM; Barak Y; Lavie M; Appelboim N; Harel Y
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):744-9. PubMed ID: 15834042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
    Yoshii F; Takagi S; Nagata E; Hasegawa Y; Kunika N; Maki F; Mochizuki H; Ogino M; Kuroiwa Y
    J Neurol Sci; 2015 Dec; 359(1-2):323-7. PubMed ID: 26671136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced information processing speed as primum movens for cognitive decline in MS.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Mult Scler; 2015 Jan; 21(1):83-91. PubMed ID: 25013149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.
    Gich J; Freixanet J; García R; Vilanova JC; Genís D; Silva Y; Montalban X; Ramió-Torrentà L
    Mult Scler; 2015 Sep; 21(10):1332-43. PubMed ID: 25716880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and decline in different MS subtypes.
    Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Polman CH
    J Neurol Sci; 2006 Jun; 245(1-2):187-94. PubMed ID: 16643951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the relationship between cognition and driving performance in multiple sclerosis.
    Schultheis MT; Weisser V; Ang J; Elovic E; Nead R; Sestito N; Fleksher C; Millis SR
    Arch Phys Med Rehabil; 2010 Mar; 91(3):465-73. PubMed ID: 20298841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT).
    Forn C; Belenguer A; Parcet-Ibars MA; Avila C
    J Clin Exp Neuropsychol; 2008 Oct; 30(7):789-96. PubMed ID: 18608672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
    Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L
    Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
    Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study.
    Glanz BI; Healy BC; Hviid LE; Chitnis T; Weiner HL
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):38-43. PubMed ID: 21746743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verbal and visuospatial memory in lateral onset Parkinson disease: time is of the essence.
    Foster PS; Drago V; Crucian GP; Skidmore F; Rhodes RD; Shenal BV; Skoblar B; Heilman KM
    Cogn Behav Neurol; 2010 Mar; 23(1):19-25. PubMed ID: 20299859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The progress of cognitive decline in newly diagnosed MS patients.
    Hankomäki E; Multanen J; Kinnunen E; Hämäläinen P
    Acta Neurol Scand; 2014 Mar; 129(3):184-91. PubMed ID: 23773012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slowed articulation rate is associated with information processing speed decline in multiple sclerosis: A pilot study.
    Friedova L; Rusz J; Motyl J; Srpova B; Vodehnalova K; Andelova M; Novotna K; Novotny M; Ruzickova H; Tykalova T; Kubala Havrdova E; Horakova D; Uher T
    J Clin Neurosci; 2019 Jul; 65():28-33. PubMed ID: 31072740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive screening in Multiple Sclerosis: the Five-Point Test as a substitute for the PASAT in measuring executive function.
    Hansen S; Muenssinger J; Kronhofmann S; Lautenbacher S; Oschmann P; Keune PM
    Clin Neuropsychol; 2017 Jan; 31(1):179-192. PubMed ID: 27707354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Normalisation and validation of the Brief Neuropsychological Battery as the reference neuropsychological test in multiple sclerosis].
    Duque P; Ibanez J; Del Barco A; Sepulcre J; de Ramon E; Fernandez-Fernandez O;
    Rev Neurol; 2012 Mar; 54(5):263-70. PubMed ID: 22362474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
    Lapshin H; Audet B; Feinstein A
    Eur J Neurol; 2014 Feb; 21(2):281-6. PubMed ID: 24200243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Landi D; Palmieri MG; Moffa F; Rinaldi P; Vernieri F; Filippi MM
    Neurol Sci; 2016 Aug; 37(8):1261-70. PubMed ID: 27095052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.